173 related articles for article (PubMed ID: 16848759)
1. Calmodulin interacts with the platelet ADP receptor P2Y1.
Arthur JF; Shen Y; Mu FT; Leon C; Gachet C; Berndt MC; Andrews RK
Biochem J; 2006 Sep; 398(3):339-43. PubMed ID: 16848759
[TBL] [Abstract][Full Text] [Related]
2. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
3. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation.
Jones S; Evans RJ; Mahaut-Smith MP
Mol Pharmacol; 2014 Sep; 86(3):243-51. PubMed ID: 24923466
[TBL] [Abstract][Full Text] [Related]
4. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
5. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
6. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
9. The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation.
Léon C; Vial C; Gachet C; Ohlmann P; Hechler B; Cazenave JP; Lecchi A; Cattaneo M
Thromb Haemost; 1999 May; 81(5):775-81. PubMed ID: 10365753
[TBL] [Abstract][Full Text] [Related]
10. Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice.
Hechler B; Zhang Y; Eckly A; Cazenave JP; Gachet C; Ravid K
J Thromb Haemost; 2003 Jan; 1(1):155-63. PubMed ID: 12871553
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
Hardy AR; Hill DJ; Poole AW
Platelets; 2005 Nov; 16(7):415-29. PubMed ID: 16236603
[TBL] [Abstract][Full Text] [Related]
12. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation by ADP: the role of ADP antagonists.
Gachet C
Ann Med; 2000 Dec; 32 Suppl 1():15-20. PubMed ID: 11209975
[TBL] [Abstract][Full Text] [Related]
14. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
Goto S; Tamura N; Ishida H; Ruggeri ZM
J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
[TBL] [Abstract][Full Text] [Related]
15. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation.
Eckly A; Gendrault JL; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2001 Apr; 85(4):694-701. PubMed ID: 11341507
[TBL] [Abstract][Full Text] [Related]
17. P2 receptors and platelet activation.
Kunapuli SP
ScientificWorldJournal; 2002 Feb; 2():424-33. PubMed ID: 12806027
[TBL] [Abstract][Full Text] [Related]
18. Platelet collagen receptor integrin alpha2beta1 activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change.
Jung SM; Moroi M
Eur J Biochem; 2001 Jun; 268(12):3513-22. PubMed ID: 11422381
[TBL] [Abstract][Full Text] [Related]
19. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function.
Mundell SJ; Jones ML; Hardy AR; Barton JF; Beaucourt SM; Conley PB; Poole AW
Mol Pharmacol; 2006 Sep; 70(3):1132-42. PubMed ID: 16804093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
